The Effect of Local Infiltration of Tranexamic Acid on Postoperative Blood Loss in Orthognathic Surgery
NCT06983886 · Status: NOT_YET_RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2025-05-21
Summary
The effect of local infiltration of tranexamic acid in orthognathic surgery remains unclear. This study was conducted to evaluate the difference in postoperative blood loss, measured by surgical drain output, following orthognathic surgery. The investigation involved a within-subject comparison, where each side of the mandible received a different local anesthetic solution: one side was infiltrated with a mixture of lidocaine with adrenaline and tranexamic acid, while the other side received lidocaine with adrenaline and normal saline.
Conditions
- Postoperative Blood Loss in Patient Undergoing Orthognathic Surgery
Interventions
- DRUG
-
Tranexamic Acid
A local anesthetic solution was prepared by mixing 10 ml of 1% lidocaine with adrenaline (1:100,000) and 5 ml of tranexamic acid (50 mg/ml), resulting in a total volume of 15 ml. The solution was injected at the planned mandibular osteotomy sites on both the medial and lateral aspects of the ramus of the mandible. The injection was administered after completion of general anesthesia, followed by a 5-minute waiting period to allow the anesthetic to take effect before the surgical incision was made.
- DRUG
-
Normal Saline Solution (NSS)
A local anesthetic solution was prepared by mixing 10 ml of 1% lidocaine with adrenaline (1:100,000) and 5 ml of normal saline (NSS), resulting in a total volume of 15 ml. The solution was injected at the planned mandibular osteotomy sites on both the medial and lateral aspects of the ramus of the mandible. The injection was administered after the induction of general anesthesia, followed by a 5-minute waiting period to allow the anesthetic to take effect before making the surgical incision.
- DRUG
-
Lidocaine (drug)
A local anesthetic solution was prepared by mixing 10 ml of 1% lidocaine with adrenaline (1:100,000) and 5 ml of normal saline (NSS) or 5 ml of tranexamic acid (50 mg/ml) depends on allocated group, resulting in a total volume of 15 ml. The solution was injected at the planned mandibular osteotomy sites on both the medial and lateral aspects of the ramus of the mandible. The injection was administered after the induction of general anesthesia, followed by a 5-minute waiting period to allow the anesthetic to take effect before making the surgical incision.
Sponsors & Collaborators
-
Ramathibodi Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-12
- Primary Completion
- 2026-06-30
- Completion
- 2026-09-30
Countries
- Thailand
Study Locations
More Related Trials
-
Prevention of Intraoperative Bleeding and Postoperative Swelling in Orthognathic Surgery Through the Use of Tranexamic Acid
NCT02229292 ·Status: COMPLETED ·Phase: PHASE4
-
Intravenous Tranexamic Acid During Rhytidectomy
NCT03970213 ·Status: UNKNOWN ·Phase: PHASE4
-
Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty
NCT02829346 ·Status: COMPLETED ·Phase: PHASE2
-
Tranexamic Acid and Head and Neck Surgery Patients
NCT00308880 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth Extraction
NCT06143787 ·Status: RECRUITING ·Phase: PHASE3
-
Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.
NCT03365999 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty
NCT01370460 ·Status: COMPLETED ·Phase: PHASE2
-
Reduction Bleeding in Laminectomy With Double Doses of Tranexamic Acid
NCT01643135 ·Status: COMPLETED ·Phase: PHASE4
-
Usefullness of Peri-operative Tranexamic Acid in Primary Breast Augmentation With Implants.
NCT03364569 ·Status: COMPLETED
-
Temporary Clamping of Drains Combined With Tranexamic Acid Reduce Blood Loss After TKA: A Prospective RCT
NCT01449552 ·Status: COMPLETED ·Phase: NA
-
A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery
NCT04803747 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Administration of Tranexamic Acid in Anterior Cruciate Ligament Surgery Reduce Postoperative Haemarthrosis
NCT04855877 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Local and Systemic Tranexamic Acid on Edema and Ecchymosis in Orbital Surgery
NCT06450392 ·Status: RECRUITING ·Phase: PHASE4
-
Randomized Clinical Trial With Aminocaproic Acid in the Prevention of Exodontic Bleeding in Anticoagulants Patients
NCT02238288 ·Status: UNKNOWN ·Phase: PHASE4
-
Prophylactic Intravenous Tranexamic Acid on Perioperative Blood Loss in Pregnant Women Undergoing Cesarean Section
NCT07078942 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Efficacy of Topical Versus Intravenous Tranexamic Acid in Controlling Blood Loss
NCT06188052 ·Status: RECRUITING ·Phase: PHASE4
-
Reducing Hypotensive Anesthesia Use with TXA During Orthognathic Surgery
NCT05474027 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Oral Versus Intravenous Tranexamic Acid
NCT04089865 ·Status: COMPLETED ·Phase: PHASE4
-
Topical Tranexamic Acid for Total Knee Arthroplasty
NCT00985920 ·Status: COMPLETED ·Phase: PHASE4
-
Tranexamic Acid in Trauma Surgery Tranexamic Acid in Trauma Surgery Tranexamic Acid in Trauma Surgery
NCT04986813 ·Status: COMPLETED ·Phase: PHASE4
-
Tranexamic Acid in Major Vascular Surgery
NCT02335359 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients
NCT01895101 ·Status: COMPLETED ·Phase: PHASE4
-
Tranexamic Acid for Total Knee Arthroscopy
NCT04443920 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Tranexamic Acid in Liposculpture
NCT04430777 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
EFFECTS OF TRANEXAMIC ACID IN TUMESCENT SOLUTION FOR LIPOSUCTION PROCEDURES
NCT06648265 ·Status: COMPLETED ·Phase: PHASE4